Instil Bio, Inc.
TIL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789769
No open-market purchases or sales by Instil Bio, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $29.2M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Instil Bio, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 62 | 64 | +2 |
| Shares | 70.4M | 71.9M | +1.44M (+2.0%) |
| Value | $1.35B | $1.28B | −$61.8M (−4.6%) |
New holders (9)
Institutions that held Instil Bio, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Beacon Pointe Advisors, LLC | 97,799 | $1.75M | 0.04% |
| Ergoteles LLC | 79,911 | $1.43M | 0.05% |
| Parametrica Management Ltd | 46,225 | $826.0K | 0.62% |
| Balyasny Asset Management LLC | 26,387 | $472.0K | 0.00% |
| M&T Bank Corp | 13,702 | $245.0K | 0.00% |
| Stifel Financial Corp | 11,500 | $206.0K | 0.00% |
| Goldman Sachs Group Inc | 10,659 | $191.0K | 0.00% |
| Migdal Insurance & Financial Holdings Ltd. | 1,479 | $26.0K | 0.00% |
| Advisor Group Holdings, Inc. | 272 | $5.00K | 0.00% |
Sold out (7)
Institutions that held Instil Bio, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Citadel Advisors LLC | 55,973 | $1.08M |
| D. E. Shaw & Co., Inc. | 42,457 | $820.0K |
| Legato Capital Management LLC | 24,393 | $471.0K |
| Sectoral Asset Management Inc | 16,878 | $326.0K |
| Zimmer Partners, LP | 13,000 | $251.0K |
| STRS Ohio | 4,000 | $77.0K |
| UBS Group AG | 714 | $14.0K |